New tool for diagnosing pulmonary embolism in emergency departments
Official title: Emergency Medicine Pulmonary Embolism Testing Multicentre Study
Run by Queen's University · NCT06320236 · Data updated 2026-11-12
This study is testing a new tool to help emergency doctors decide when imaging for pulmonary embolism is really needed, aiming to reduce unnecessary scans and radiation exposure for patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 4000 (estimated) |
| Sponsor | Queen's University Academic / other |
| Drugs / interventions | radiation |
| Locations | 4 sites (Hamilton, Ontario and 3 other locations) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | September 30, 2026 |
| Study ends | September 30, 2027 |
| Registry record updated | April 20, 2026 |
| Trial ID | NCT06320236 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are emergency department patients being tested for pulmonary embolism.
✕Probably not a fit
Patients who have had recent imaging for PE or deep vein thrombosis, or those with other contraindications, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the effectiveness of the Adjust-Unlikely clinical decision rule in reducing unnecessary imaging for pulmonary embolism (PE) in emergency department patients. The Adjust-Unlikely tool, developed by a team of researchers and emergency physicians, is designed to be highly sensitive and user-friendly for emergency settings. By implementing this decision rule, the study seeks to minimize the exposure of patients to radiation and reduce healthcare costs associated with unnecessary imaging. The study will involve patients who are tested for PE in emergency departments across Canada.
Why it matters
Potential benefit: If successful, this approach could significantly decrease unnecessary imaging for pulmonary embolism, improving patient safety and reducing healthcare costs.
How similar studies have gone: Other studies have shown promise in using clinical decision rules to reduce unnecessary imaging, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Emergency department patient who is tested by an emergency physician for PE Exclusion Criteria: * Patient is \< 18 years of age * No documentation of whether PE is the most likely diagnosis * D-dimer is not tested or else not resulted during the emergency visit * The D-dimer level is known before documentation of whether PE is the most likely diagnosis * The D-dimer is ordered prior to the physician assessing the patient * The patient has previously registered that they opt out of all research at the participating site * The patient leaves against medical advice * The patient has had PE or deep vein thrombosis imaging (CT pulmonary angiogram, ventilation-perfusion scan or lower limb ultrasound) within prior 30 days * There is a new (non-PE) indication for anticoagulation * The patient was initiated on treatment for presumed PE prior to PE testing * The patient has previously been enrolled into the study * The patient has a prior history of lower extremity deep vein thrombosis without availability of a baseline ultrasound scan * The patient was transferred from another hospital organization * The patient does not reside in Ontario * The patient has no valid Ontario Health Insurance Plan card
Where it's running
-
Hamilton Health Sciences Corporation
Hamilton, Ontario, Canada Recruiting -
Kingston Health Sciences Centre
Kingston, Ontario, Canada Recruiting -
London Health Sciences Centre Research Inc
London, Ontario, Canada Active not recruiting -
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada Active not recruiting
Study contacts
- Principal investigator: Kerstin de Wit, MD — Queens University
- Study coordinator: Natasha S Clayton
- Email: natasha.clayton@queensu.ca
- Phone: 416-566-3590
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI analysis of ECGs to detect structural heart disease
This project will test whether AI can read traditional and wearable ECGs to find undiagnosed valve disease, pulmonary hypertension, and heart failure in adults.
-
TRiP-cast score test in adults with acute lower-limb injuries requiring immobilization
This study tests whether the TRiP(cast) score can predict risk of blood clots in adults with acute lower-limb injuries treated as outpatients.
-
Prognostic value of the 2026 AHA/ACC PE classification in ED patients with acute PE
This study tests whether the 2026 AHA/ACC five-category PE classification helps predict 30-day major adverse pulmonary embolism events in adults with acute PE presenting to the ED.
-
Right heart dysfunction in acute pulmonary embolism: can echocardiography help predict risk
This study tests whether transthoracic echocardiography can identify right ventricular dysfunction in adults with acute pulmonary embolism to help gauge risk.
-
Heart failure with preserved ejection fraction in people with COPD: clinical course and prognosis
This project will see how often HFpEF appears in people aged 50–70 hospitalized with COPD and whether having HFpEF changes their symptoms, exercise capacity, and prognosis.
-
Aspiration thrombectomy with the Symphony or Prodigy devices
This project will try the Symphony and Prodigy aspiration thrombectomy devices to remove arterial, venous, or pulmonary blood clots in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.